$3.57
0.3711.66%
At close: -
$3.65
0.072.07%
After Hours: 4:52 PM EDT
LakeShore Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of LakeShore Biopharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-15 | $-1.90 | $-0.90 | -111.1 % |
Mar 2024 | 2024-04-19 | $-1.20 | $-0.70 | -71.4 % |
Dec 2023 | 2024-01-22 | $-1.60 | $-0.80 | -100.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-15 | $3.77M | $24.25M | -84.5 % |
Mar 2024 | 2024-04-19 | $23.82M | $22.84M | 4.27 % |
Dec 2023 | 2024-01-22 | $13.64M | $23.11M | -41.0 % |
LakeShore Biopharma (LSB) is scheduled to report earnings on January 21, 2025. The last reported earnings were for reported on August 15, 2024 for Q4.
The Actual EPS was $-1.90, which missed the estimate of $-0.90.
The Actual Revenue was $3.8M, which missed the estimate of $24.3M.
Browse earnings estimates, EPS, and revenue on all stocks.